(JAZZ) Jazz Pharmaceuticals - Performance 4% in 12m
JAZZ performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-19.27%
#84 in Peer-Group
Rel. Strength
44.84%
#4227 in Stock-Universe
Total Return 12m
3.99%
#67 in Peer-Group
Total Return 5y
4.47%
#67 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 14.9 |
| P/E Forward | 12.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 144.17 USD |
| 52 Week Low | 97.78 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 67.57 |
| Buy/Sell Signal +-5 | -1.09 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: JAZZ (4%) vs XLV (-6.7%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.9% | 131% | 354% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
2.5% | 13.5% | 82% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-1.93% | -14.5% | 419% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.79% | 0.39% | 50.8% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-8.02% | 2.74% | 50.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-3.54% | -6.89% | 49.9% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-6.74% | -9.61% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
3.73% | 19% | 62.6% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: JAZZ vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for JAZZ
| Total Return (including Dividends) | JAZZ | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -0.21% | 0.06% | 4.01% |
| 3 Months | 9.72% | -0.76% | 17.14% |
| 12 Months | 3.99% | -6.69% | 13.46% |
| 5 Years | 4.47% | 44.47% | 112.73% |
| Trend Score (consistency of price movement) | JAZZ | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 20.1% | 32.3% | 90.3% |
| 3 Months | 27.5% | -15.4% | 97.5% |
| 12 Months | -0.7% | -78.9% | 46.4% |
| 5 Years | -67.9% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th45.50 | -0.27% | -4.06% |
| 3 Month | %th37.00 | 10.56% | -6.34% |
| 12 Month | %th67.50 | 11.45% | -8.35% |
| 5 Years | %th64.50 | -27.68% | -50.89% |
FAQs
Does Jazz Pharmaceuticals (JAZZ) outperform the market?
Yes,
over the last 12 months JAZZ made 3.99%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.69%.
Over the last 3 months JAZZ made 9.72%, while XLV made -0.76%.
Performance Comparison JAZZ vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
JAZZ vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2% | -4.2% | -18.4% | -9% |
| US NASDAQ 100 | QQQ | 2.1% | -4.4% | -20.4% | -9% |
| German DAX 40 | DAX | 1.7% | -1.4% | -30.5% | -26% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.8% | -4.8% | -22.8% | -15% |
| Hongkong Hang Seng | HSI | 1.1% | -3% | -40.4% | -31% |
| India NIFTY 50 | INDA | 3.4% | 0.6% | -18.8% | 7% |
| Brasil Bovespa | EWZ | 6.2% | 0.4% | -33.4% | 3% |
JAZZ vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.4% | -1.9% | -21.7% | -20% |
| Consumer Discretionary | XLY | 1.1% | -3.6% | -10.7% | -14% |
| Consumer Staples | XLP | 4.1% | -0.1% | -17.4% | -3% |
| Energy | XLE | -0.9% | -4.3% | -10.8% | 2% |
| Financial | XLF | 3.5% | -2.8% | -20.7% | -21% |
| Health Care | XLV | 1.9% | -0.3% | -6.9% | 11% |
| Industrial | XLI | 1.6% | -4.7% | -24.2% | -19% |
| Materials | XLB | 1.3% | -4.7% | -19% | -0% |
| Real Estate | XLRE | 2.3% | -0.1% | -16.9% | -4% |
| Technology | XLK | 2.1% | -6.8% | -23.5% | -7% |
| Utilities | XLU | 1.9% | -2.8% | -22.4% | -16% |
| Aerospace & Defense | XAR | 1.4% | -7.1% | -38.4% | -45% |
| Biotech | XBI | -1.6% | -3.4% | -8.1% | 15% |
| Homebuilder | XHB | -1.1% | -9% | -11.8% | 5% |
| Retail | XRT | 2.1% | -3.5% | -13.5% | -2% |
JAZZ vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.4% | -3.51% | -4.46% | 9% |
| Natural Gas | UNG | 3.7% | 6.3% | 7.6% | 6% |
| Gold | GLD | 1.9% | -0.5% | -36.3% | -34% |
| Silver | SLV | -2.3% | -6.5% | -40.4% | -18% |
| Copper | CPER | -8.3% | -15.2% | -37.9% | -19% |
JAZZ vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.9% | -0.2% | -13.1% | 8% |
| iShares High Yield Corp. Bond | HYG | 2.6% | -1.3% | -15.4% | -5% |